By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Regen BioPharma  

4700 Spring Street
Suite 304
La Mesa  California  91942  U.S.A.
Phone: 619-702-1404 Fax: 619-330-2328


Company News
Regen BioPharma President Harry Lander Provides Mid-Year Update On Company's Progress And Developments 7/13/2016 6:30:55 AM
Regen BioPharma Enters Into Open Innovation Drug Discovery Program Agreement With Eli Lilly (LLY) 6/30/2016 6:41:11 AM
Regen BioPharma 's Small Molecule Drug Screening Program Uncovers Activators Of NR2F6 6/15/2016 10:58:06 AM
Regen BioPharma Retains Objective Capital Partners, LLC To Explore Non-Dilutive Funding Opportunities 6/8/2016 9:26:04 AM
Regen BioPharma Discusses Its Major Small Molecule Drug Screening Program Targeting Immune Checkpoint NR2F6 6/2/2016 11:20:13 AM
Regen BioPharma Uplisted To Trade Publicly On OTCQB 6/1/2016 4:06:01 PM
Regen BioPharma Files Application To Trade Publicly On OTCQB 5/24/2016 10:22:14 AM
Regen BioPharma Announces ucVax: Universal Donor Cancer Cellular Immunotherapy 5/19/2016 11:18:09 AM
Regen BioPharma Discusses Recent Developments In Aplastic Anemia Therapy And Future Potential Expansion Of HemaXellerate 5/11/2016 8:30:54 AM
Regen BioPharma Receives Preliminary Clinical Data From Pan Am Cancer Center Regarding Their HemaXellerate Study In Cancer Patients 5/3/2016 7:26:32 AM